Related Experiment Video
Updated: May 7, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Maternal infections during pregnancy and cerebral palsy: a population-based cohort study
Jessica E Miller1, Lars Henning Pedersen, Elani Streja
1Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA.
Insights
Maternal genito-urinary tract infections and antibiotic use during pregnancy are linked to a higher risk of cerebral palsy (CP) in children. These findings suggest prenatal infections may play a role in CP development.
Area of Science:
- Obstetrics and Gynecology
- Pediatrics
- Neurology
Background:
- Cerebral palsy (CP) is a prevalent motor disability affecting children.
- Understanding risk factors for congenital CP is crucial for prevention strategies.
Purpose of the Study:
- To investigate the association between maternal infections during pregnancy and the risk of congenital CP.
- To identify specific types of infections and antibiotic use linked to CP development.
Main Methods:
- A cohort study of liveborn singletons in Denmark (1997-2003) was conducted.
- Maternal infections and antibiotic redemption were used as exposure markers.
- Cox proportional hazard models were employed to estimate adjusted hazard ratios (HR) and 95% confidence intervals (CI).
Main Results:
- Maternal genito-urinary tract infections were associated with an increased risk of CP (HR 2.1, 95% CI 1.4, 3.2).
- Antibiotic use, specifically nitrofurantoin, showed an association with CP (HR 1.7, 95% CI 1.1, 2.8).
- CP risk was elevated with antibiotic prescriptions in the first trimester and genito-urinary tract infections in the third trimester.
Conclusions:
- Genito-urinary tract infections and antibiotic use during pregnancy are associated with increased CP risks.
- Prenatal infections and their treatment may be part of the causal pathway for CP.
Background:
Cerebral palsy (CP) is a common motor disability in childhood. We examined the association between maternal infections during pregnancy and the risk of congenital CP in the child.
Methods:
Liveborn singletons in Denmark between 1997 and 2003 were identified from the Danish National Birth Registry and followed from 1 year of life until 2008. Redemption of antibiotics from the National Register of Medicinal Product Statistics and maternal infections reported by the National Hospital Register were used as markers of maternal infection during pregnancy. CP diagnoses were obtained from the Danish Cerebral Palsy Registry. Adjusted hazard ratio (HR) and 95% confidence interval (CI) were estimated by Cox proportional hazard models.
Results:
Of the 440 564 singletons with follow-up data, 840 were diagnosed with congenital CP. Maternal genito-urinary tract infections (HR 2.1, 95% CI 1.4, 3.2) were associated with CP in all births, in term births (HR 1.9, 95% CI 1.1, 3.2), in children with spastic CP (HR 2.1, 95% CI 1.4, 3.3), and among first-born children (HR 1.9, 95% CI 1.4, 3.3). Overall, we found associations between redeemed nitrofurantoin (HR 1.7, 95% CI 1.1, 2.8) and CP. Among trimester-specific exposures, CP risk was associated with prescriptions redeemed in the first trimester for any antibacterials, beta-lactam antibacterials, and nitrofurantoin, an antibiotic commonly used to treat lower urinary tract infection, and genito-urinary tract infections in the third trimester.
Conclusion:
Genito-urinary tract infections and antibiotic use during pregnancy were associated with increased risks of CP, indicating that some maternal infections or causes of maternal infections present in prenatal life may be part of a causal pathway leading to CP.
More Related Videos
07:13Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C
Published on: March 25, 2016
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
Development of the Oral Microbiota
Encephalitis l: Introduction
Bacterial Meningitis I: Introduction
Teratogenicity
Cytomegalovirus Disease
Bacterial Meningitis II: Pathophysiology